FRUMIL furosemide (frusemide) 40 mg and amiloride hydrochloride dihydrate 5 mg tablets

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

furosemide, Quantity: 40 mg; amiloride hydrochloride dihydrate, Quantity: 5 mg

MAH:

Sanofi-Aventis Australia Pty Ltd

INN:

amiloride hydrochloride dihydrate,furosemide (frusemide)

pharmaceutical_form:

Tablet, uncoated

composition:

Excipient Ingredients: microcrystalline cellulose; sodium starch glycollate type A; maize starch; sunset yellow FCF; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; purified talc

administration_route:

Oral

units_in_package:

28

prescription_type:

(S1) This Schedule is intentionally blank

therapeutic_indication:

FRUMIL is indicated for the treatment of cardiac failure, in patients who require diuretics plus potassium supplements, or potassium sparing diuretics.

leaflet_short:

Visual Identification: Orange tablets with breakline; FRUMIL on reverse side.; Container Type: Blister Pack; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2007-08-20